A stenotic or hypoplastic portal vein (PV) represents a challenge for PV reconstruction in pediatric living donor liver transplantation (LDLT). Several PV venoplastic techniques have been developed. However, we still seek improved venoplastic techniques with better efficacy and compatibility. From June 2016 to July 2017, 271 LDLT procedures were performed at the Department of Liver Surgery, Renji Hospital. A total of 16 consecutive children with stenotic and sclerotic PVs underwent a novel technique-the autogenous PV patch plastic technique. Vessel patches were procured from the left branch (LB), or the bifurcation of the right branch and LB of the PV in the native liver. Then, the PVs were enlarged by suturing the patches along the longitudinal axis from the confluence of the PV and coronary vein (CV). In this series, 15/ 16 achieved good intraoperational PV flow, and 1 showed low PV flow but was treated with stent placement. Within a median follow-up of 11 months (1-18 months), 15 patients were alive and had normal graft function, whereas 1 child died from lung infection 1 month after transplantation. No PV complications were detected. In conclusion, the autogenous patch venoplasty technique using the PV-CV confluence is simple and safe. This novel venoplastic reconstruction technique could serve as a surgical option to achieve satisfactory outcomes, especially those with stenotic PV (<4.5 mm) and dilated CV (>3.0 mm).
Portal vein (PV) reconstruction is an essential procedure in living donor liver transplantation (LDLT). However, several risk factors may result in reconstruction failure and graft loss. (1, 2) A hypoplastic PV, which is characterized by a very small diameter and sclerotic quality of the vessel caused by recurrent cholangitis after a Kasai procedure or lymph node compression around the porta hepatis, is the primary threat to successful reconstruction. The risk of low PV flow is approximately 10% in pediatric LDLTs (3) and can be even higher in very small recipients with PV hypoplasia. Venoplasty is inevitable in children with severe PV hypoplasia. Innovative techniques have been developed to achieve sustained PV patency and graft function after LDLT. Briefly, these techniques include anastomosis to the junction of the splenic vein (SV) and superior mesenteric vein (SMV), with or without endto-end (4) or end-to-side (5) conduits, and PV enlargement via vessel patches from various sources. (6) However, some data suggest a higher rate of PV thrombosis after interposition PV reconstruction, (7, 8) especially with cryopreserved vessels. (9) Moreover, vessel grafts procured from normal tissues of donors or recipients may result in additional injury and increase reconstruction time. Additionally, extensive dissection of the PV to the confluence of the SMV and the SV is associated with a risk of bleeding and chylous ascites. On the basis of these limitations, we seek better techniques for PV venoplasty and systematically present a novel PV Abbreviations: BA, biliary atresia; BB, bifurcation branch; BD, biliary duct; CTA, computed tomography angiography; CV, coronary vein; GRWR, graft-to-recipient-weight ratio; HV, hepatic vein; LB, left branch; LDLT, living donor liver transplantation; LL, left lobe; LLS, lateral left segment; MHV, middle hepatic vein; PELD, pediatric end-stage liver disease; PFIC, progressive familial intrahepatic cholestasis; post-PV diameter, portal vein diameter after venoplasty; pre-PV diameter, portal vein diameter before venoplasty; PV, portal vein; RL, right lobe; SMV, superior mesenteric vein; SV, splenic vein; US, ultrasound.
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reconstruction technique-autogenous PV patch plastic reconstruction.
Patients and Methods

PATIENTS AND CHARACTERISTICS
From June 2016 to July 2017, 271 LDLT procedures were performed at the Department of Liver Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University. All LDLT procedures were approved by the ethics committee of Renji Hospital and were performed in accordance with the relevant regulations. Organs from executed prisoners were prohibited. Sixteen children were considered high-risk cases based on poor PV characteristics, such as intratransplantation observation of small size (<4.5 mm) and sclerotic quality, and reverse PV flow as determined by Doppler. The coronary vein (CV) was measured on computed tomography angiography (CTA) before transplantation, and the measurements were confirmed during transplantation. We performed autogenous patch venoplastic PV reconstruction in these high-risk cases.
TECHNIQUES OF AUTOGENOUS PATCH VENOPLASTIC RECONSTRUCTION
The venoplastic technique aims to enlarge the stenotic PV in high-risk patients without causing additional injury in normal tissues in donors and recipients. As shown in Fig. 1 , a vessel patch of good quality and sufficient length could be obtained by the following:
1. Dissecting the left branch (LB) of the PV toward the round ligament in a recipient's resected liver, or 2. Exposing the "T"-shape bifurcation of the right branch and LB of the PV with sufficient length and then procuring the transverse portion of the vessel as a patch.
The patch could be easily trimmed to a suitable size for anastomosis as needed.
For recipient preparation, the native PV was dissected down to the confluence of the SMV and the SV or the dilated CV during the exploration of the native liver. The gastroduodenal artery should be dissected to achieve good exposure. Next, the hypoplastic native PV was opened longitudinally to the level of the CV, and the patch was sutured in a side-to-side manner as shown in Fig. 2 . The entire stenotic portion of the PV must be enlarged by the patch to avoid the presence of narrow regions. Moreover, the diameter of the PV after venoplasty should be kept within a range that is suitable for anastomosis to graft the PV. The anastomosis was completed with continuous 6-0 polydioxanone sutures. Before unclamping, heparin-containing saline was used to flush the vessel to remove any possible clots. Care was taken to adjust the alignment of the reconstructed PV and avoid kinking or bending.
POSTOPERATIVE MANAGEMENT
At the completion of PV reconstruction and the completion of transplantation, Doppler ultrasound (US) was used to estimate the PV flow. Doppler US tests were performed in all the recipients daily in the first week after LT, every 2 days in the second week, monthly during the first 6 months, and every 3 months thereafter. The anticoagulant regimen included intravenous heparin for 2 weeks. Furthermore, warfarin was recommended in the children who received a PV stent to maintain a prothrombin time-international normalized ratio at 1.5-2.0.
Results
CHARACTERISTICS OF RECIPIENTS AND DONORS
The profiles of all the 271 LDLTs are presented in Table 1 . A consecutive series of recipients accepting PV venoplasty included 4 boys and 12 girls with a median age of 7.0 months (range, 6.0-16.0 months) and a median weight of 6.8 kg (range, 5.1-9.7 kg). All of the children suffered from biliary atresia (BA) except for 1 who had progressive familial intrahepatic cholestasis (PFIC). Reversed PV flow was observed on preoperative Doppler US in 8 patients, and fluctuant PV flow was observed in 3 patients. The detailed individual characteristics of each child accepting venoplasty were shown in Table 2 .
OPERATIONAL RESULTS OUTCOMES
The overall surgical complications of these 271 LDLTs include intra-abdominal bleeding (2/271), hepatic artery thrombosis (2/271), hepatic vein (HV) stenosis (3/271), PV stenosis (2/271), low PV flow during surgery (16/271), biliary complication (2/271), and bowel perforation (3/271). For the 16 venoplasty patients, all of them obtained satisfactory portal flow after LDLT, and no PV-related complications were observed in the subsequent follow-up. Graft function recovered within no more than 2 weeks. During the median follow-up of 11 months (range, 1-18 months), only 1 child died of severe pulmonary infection. The For the 16 LDLTs using PV venoplasty, the grafts were all left lateral segments, with size reduction in 4 patients. The median GRWR was 3.36% (2.64%-5.77%). The median time for PV reconstruction was 32 minutes (28-36 minutes), and the median hepatic phase was 48 minutes (40-61 minutes). The median PV diameter was 3.5 mm (1.5-4.5 mm), and the median CV diameter was 3.7 mm (1.1-5.1 mm). The patch was procured from the LB in 14 patients and from the bifurcation of the PV in 2 patients. The median length of the patches was 37.0 mm (31.0-42.0 mm), and the median width was 7.0 mm (5.0-9.0 mm). A total of 13/16 anastomoses were constructed on the confluence of the PV and the CV. After venoplasty, PVs were enlarged to a median diameter of 5.1 mm (3.7-6.2 mm). All of the grafts showed good early function with acidosis correction and bile production during transplantation. Intraoperative US showed satisfactory PV flow in all but 1 child, whose PV flow was still less than 20 cm/ second, so a stent was placed as described previously. (10) Detailed information is shown in Table 2 .
Discussion
Hypoplasia of the PV is not uncommon in children indicated for liver transplantation, especially those with BA. In this series, most (15/16) of the children requiring PV venoplasty suffered from BA. The small size of the vein must be corrected for successful PV reconstruction. Several venoplasty techniques have been developed to enlarge the diameter of the PV, including replacement of the PV down to the confluence of the SMV and the SV with graft vessels for several anastomoses, (4, 11, 12) or the insertion of a graft patch to enlarge the diameter, (6) or reconstruction in an ellipsoid fashion. (13) On the basis of the published data, the PV complication rate varies between the 2 major PV venoplasty techniques. The early PV thrombosis incidence varies from 8% to 33% after LDLT using PV conduits. (14) An improved technique using PV conduits showed better results, achieving a 100% patency remaining children are all doing well and show good PV patency. Figure 3 shows a representative patient (number 2) of a severely hypoplastic PV that was treated with venoplastic PV reconstruction. After 17 months, this patient is doing very well, and CTA at 16 months after the operation revealed a patent PV and intact confluence of the SMV-SV. Overall, the 3-month, 6-month, and 12-month survival rate is 96.5%, 95.3%, and 95.3%, respectively, of all the 271 LDLTs.
rate, but the data are from cadaveric liver transplantation. (11) For venoplasty with graft patch insertion, the data appear to be better, with PV stenosis in only 1 of 26 patients. (6) Several studies emphasize the disadvantages of cryopreserved vessel grafts, (9, 15, 16) which may explain the inferior result for PV conduits. Therefore, PV venoplasty with a fresh autogenous vessel graft may be the optimal strategy for PV reconstruction.
Our present technique is derived from the reported graft patch technique. (6, 17) Improvements to the technique were implemented in terms of the autogenous source of the patch and alternative sites for patch insertion. First, the native liver, which is usually discarded, is a suitable source of patches. Immediately after excision of the native liver, a vessel patch can be procured from 2 sites: the LB of the PV toward the round ligament or the transverse portion of the bifurcation of the right branch and LB of the PV. The decision is made based on the recipient's PV. In our series, 2/16 children had a standard bifurcation with sufficient length of the right branch. Therefore, this branch of the bifurcation was trimmed into a patch. A patch from the LB can be safely procured in most patients by tracing it toward the round ligament. The quality of the patch is always good. Second, a dilated CV is common in children with chronic hepatofugal PV flow secondary to cirrhosis and represents a risk for low PV flow. In our venoplastic technique, the CV was measured on CTA before transplantation and was dissected and ligated. The proximal stump of the CV was used as part of the confluence for patch insertion. This technique increases PV flow via CV ligation, avoids unnecessary access to the SMV, and preserves the SMV-SV confluence, which is important for future use. Overall, these improvements simplify patch procurement without injuring normal tissues and provide another anatomic site that is easier to access. Additionally, fresh autogenous patches have better histocompatibility and a low risk of infection compared with patches from other sources, especially cryopreserved cadaveric vessels. It is essential to choose patients indicated for this technique. The diameter of the PV trunk should be the first important factor when making the decision to use a patching venoplasty. There were studies suggesting that a patient with a PV of < PV plastic reconstruction, (18) and a PV of <5.0 mm was a risk factor of PV complication. (19) On the basis of our experience, a PV of <4.5 mm is a safe value to justify a venoplasty using a patch to enlarge the diameter. The other important consideration in choosing to use this novel technique or not is CV diameter. Our data demonstrated satisfactory results with 15/16 patients exhibiting intraoperative PV patency. For the 1 patient who failed the technique, the CV was very thin (1.7 mm; patient 3 in Table 2 ) and the PV was not enlarged enough (3.0-3.7 mm). This failure led us to choose the SMV-SV confluence as the patch site in patients with a nondilated CV (patients 4, 10, and 11 in Table 2 ), which achieved a perfect patency rate. Therefore, we recommend evaluating the CV before choosing the PV-CV confluence as the initial patch site, which can be assessed on CTA before transplantation and by observation during surgery. On the basis of our data, the PV-CV confluence is a safe choice when the CV diameter is larger than 3.0 mm.
During the maximal follow-up period of 18 months, no PV complications occurred in this venoplasty series, and all the children are in good health, except for 1 4.0 mm should be considered for child who died from lung infection. Although longer follow-up is still required, these encouraging results confirm the efficacy and safety of this improved venoplasty technique and support its routine application in pediatric LDLT.
Our study has several limitations such as the study being retrospective and nonrandomized and the relatively short follow-up. Since we started to apply this current autogenous patching technique from 18 months before, we could only reach a decent length of follow-up time. However, we will keep following up these series of patients and report longterm outcomes in the future. Moreover, ever since the establishment of a pediatric liver transplantation program in our center in 2006, both the number and survival of LDLTs improved dramatically with the evolution of surgical techniques and the accumulation of experience. (20) We are obligated to seek a better technique in venoplasty and to conduct a better designed prospective clinical study.
In conclusion, our novel PV venoplastic technique enlarges a hypoplastic PV through the insertion of an autogenous PV patch down to the site of normal size, which can be the confluence of the PV and the CV. An autogenous patch is easily procured without additional injury and provides better histocompatibility. Thus, it could be considered in all the venoplastic techniques using a patch. The patency rate and graft survival rate are satisfactory. We believe that this technique is a good choice in pediatric liver transplantation with stenotic PV (<4.5 mm) and dilated CV (>3.0 mm).
